<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9295451</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">35865354</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9295451</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fnhum.2022.882114</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Characteristics of participants included in the study.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T1"><label>Table 1</label><caption><p>Characteristics of participants included in the study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Condition</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>TAO group</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>HC group</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>t</italic></bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic>-value<xref rid="TN1" ref-type="table-fn">*</xref></bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender (male/female)</td><td valign="top" align="center" rowspan="1" colspan="1">14/7</td><td valign="top" align="center" rowspan="1" colspan="1">14/7</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td><td valign="top" align="center" rowspan="1" colspan="1">&gt;0.999</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="center" rowspan="1" colspan="1">54.17 ± 4.83</td><td valign="top" align="center" rowspan="1" colspan="1">55.17 ± 5.37</td><td valign="top" align="center" rowspan="1" colspan="1">−0.348</td><td valign="top" align="center" rowspan="1" colspan="1">0.745</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Duration (months)</td><td valign="top" align="center" rowspan="1" colspan="1">11.25 ± 4.42</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td><td valign="top" align="center" rowspan="1" colspan="1">N/A</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BCVA-OD</td><td valign="top" align="center" rowspan="1" colspan="1">0.67 ± 0.35</td><td valign="top" align="center" rowspan="1" colspan="1">1.14 ± 0.15</td><td valign="top" align="center" rowspan="1" colspan="1">−4.462</td><td valign="top" align="center" rowspan="1" colspan="1">0.026</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">BCVA-OS</td><td valign="top" align="center" rowspan="1" colspan="1">0.64 ± 0.29</td><td valign="top" align="center" rowspan="1" colspan="1">1.06 ± 0.23</td><td valign="top" align="center" rowspan="1" colspan="1">−4.297</td><td valign="top" align="center" rowspan="1" colspan="1">0.023</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IOP</td><td valign="top" align="center" rowspan="1" colspan="1">25.63 ± 3.36</td><td valign="top" align="center" rowspan="1" colspan="1">14.45 ± 1.07</td><td valign="top" align="center" rowspan="1" colspan="1">5.532</td><td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Education</td><td valign="top" align="center" rowspan="1" colspan="1">11.17 ± 2.64</td><td valign="top" align="center" rowspan="1" colspan="1">11.42 ± 1.95</td><td valign="top" align="center" rowspan="1" colspan="1">−0.269</td><td valign="top" align="center" rowspan="1" colspan="1">0.861</td></tr></tbody></table><table-wrap-foot><p><italic>Independent samples t-test for the other normally distributed continuous data (means ± SD).</italic></p><fn id="TN1"><label>*</label><p><italic>p &lt; 0.05 indicated significant differences.</italic></p></fn><p><italic>TAO, thyroid-associated ophthalmopathy; HC, healthy control; N/A, not applicable; BCVA, best corrected visual acuity; OD, oculus dexter; OS, oculus sinister; IOP, intraocular pressure</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Characteristics of participants included in the study.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Condition</th><th valign="top" align="center">TAO group</th><th valign="top" align="center">HC group</th><th valign="top" align="center">t</th><th valign="top" align="center">P-value???</th></tr></thead><tbody><tr><td valign="top" align="left">Gender (male/female)</td><td valign="top" align="center">14/7</td><td valign="top" align="center">14/7</td><td valign="top" align="center">N/A</td><td valign="top" align="center">&gt;0.999</td></tr><tr><td valign="top" align="left">Age (years)</td><td valign="top" align="center">54.17 ± 4.83</td><td valign="top" align="center">55.17 ± 5.37</td><td valign="top" align="center">−0.348</td><td valign="top" align="center">0.745</td></tr><tr><td valign="top" align="left">Duration (months)</td><td valign="top" align="center">11.25 ± 4.42</td><td valign="top" align="center">N/A</td><td valign="top" align="center">N/A</td><td valign="top" align="center">N/A</td></tr><tr><td valign="top" align="left">BCVA-OD</td><td valign="top" align="center">0.67 ± 0.35</td><td valign="top" align="center">1.14 ± 0.15</td><td valign="top" align="center">−4.462</td><td valign="top" align="center">0.026</td></tr><tr><td valign="top" align="left">BCVA-OS</td><td valign="top" align="center">0.64 ± 0.29</td><td valign="top" align="center">1.06 ± 0.23</td><td valign="top" align="center">−4.297</td><td valign="top" align="center">0.023</td></tr><tr><td valign="top" align="left">IOP</td><td valign="top" align="center">25.63 ± 3.36</td><td valign="top" align="center">14.45 ± 1.07</td><td valign="top" align="center">5.532</td><td valign="top" align="center">&lt;0.001</td></tr><tr><td valign="top" align="left">Education</td><td valign="top" align="center">11.17 ± 2.64</td><td valign="top" align="center">11.42 ± 1.95</td><td valign="top" align="center">−0.269</td><td valign="top" align="center">0.861</td></tr></tbody></table></div>Independent samples t-test for the other normally distributed continuous data (means ± SD).*p &lt; 0.05 indicated significant differences.TAO, thyroid-associated ophthalmopathy; HC, healthy control; N/A, not applicable; BCVA, best corrected visual acuity; OD, oculus dexter; OS, oculus sinister; IOP, intraocular pressure.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2</table-label><table-caption>Brain areas with significantly altered VMHC values between two groups.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T2"><label>Table 2</label><caption><p>Brain areas with significantly altered VMHC values between two groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Regions</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Cluster</bold><break/><bold>size</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Brodmann's</bold><break/><bold>areas</bold></th><th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;" rowspan="1"><bold>MNI coordination</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>T</italic> value</bold></th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>X</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Y</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Z</bold></th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">R/L-PostCG/LING/CAL</td><td valign="top" align="center" rowspan="1" colspan="1">2,243</td><td valign="top" align="center" rowspan="1" colspan="1">3/4/18/19</td><td valign="top" align="center" rowspan="1" colspan="1">± 3</td><td valign="top" align="center" rowspan="1" colspan="1">−21</td><td valign="top" align="center" rowspan="1" colspan="1">27</td><td valign="top" align="center" rowspan="1" colspan="1">−4.9477</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">R/L-MTG</td><td valign="top" align="center" rowspan="1" colspan="1">13</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">± 39</td><td valign="top" align="center" rowspan="1" colspan="1">−63</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">−3.0776</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">R/L-MOG/ANG</td><td valign="top" align="center" rowspan="1" colspan="1">27</td><td valign="top" align="center" rowspan="1" colspan="1">19/39</td><td valign="top" align="center" rowspan="1" colspan="1">± 45</td><td valign="top" align="center" rowspan="1" colspan="1">−78</td><td valign="top" align="center" rowspan="1" colspan="1">33</td><td valign="top" align="center" rowspan="1" colspan="1">−3.3491</td></tr></tbody></table><table-wrap-foot><p><italic>TAO, thyroid-associated ophthalmopathy; MNI, Montreal Neurological Institute; VMHC, voxel-mirrored homotopic connectivity; PostCG, postcentral gyrus; LING, lingual gyrus; CAL, calcarine; MTG, middle temporal gyrus; MOG, middle occipital gyrus; ANG, angular gyrus</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Brain areas with significantly altered VMHC values between two groups.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Regions</th><th valign="top" align="center">Clustersize</th><th valign="top" align="center">Brodmann'sareas</th><th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;">MNI coordination</th><th valign="top" align="center">T value</th></tr><tr><th/><th/><th/><th valign="top" align="center">X</th><th valign="top" align="center">Y</th><th valign="top" align="center">Z</th><th/></tr></thead><tbody><tr><td valign="top" align="left">R/L-PostCG/LING/CAL</td><td valign="top" align="center">2,243</td><td valign="top" align="center">3/4/18/19</td><td valign="top" align="center">± 3</td><td valign="top" align="center">−21</td><td valign="top" align="center">27</td><td valign="top" align="center">−4.9477</td></tr><tr><td valign="top" align="left">R/L-MTG</td><td valign="top" align="center">13</td><td valign="top" align="center">-</td><td valign="top" align="center">± 39</td><td valign="top" align="center">−63</td><td valign="top" align="center">3</td><td valign="top" align="center">−3.0776</td></tr><tr><td valign="top" align="left">R/L-MOG/ANG</td><td valign="top" align="center">27</td><td valign="top" align="center">19/39</td><td valign="top" align="center">± 45</td><td valign="top" align="center">−78</td><td valign="top" align="center">33</td><td valign="top" align="center">−3.3491</td></tr></tbody></table></div>TAO, thyroid-associated ophthalmopathy; MNI, Montreal Neurological Institute; VMHC, voxel-mirrored homotopic connectivity; PostCG, postcentral gyrus; LING, lingual gyrus; CAL, calcarine; MTG, middle temporal gyrus; MOG, middle occipital gyrus; ANG, angular gyrus.</transformed-table></extracted-table><extracted-table><table-id>T3</table-id><table-label>Table 3</table-label><table-caption>Significant differences in seed-based FC between TAO patients and HCs.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T3"><label>Table 3</label><caption><p>Significant differences in seed-based FC between TAO patients and HCs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Seed region</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Regions</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Cluster</bold><break/><bold>size</bold></th><th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;" rowspan="1"><bold>MNI coordination</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic> value</bold></th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>X</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Y</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Z</bold></th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">R-PostCG/LING/CAL</td><td valign="top" align="left" rowspan="1" colspan="1">L-LING</td><td valign="top" align="center" rowspan="1" colspan="1">282</td><td valign="top" align="center" rowspan="1" colspan="1">−12</td><td valign="top" align="center" rowspan="1" colspan="1">−60</td><td valign="top" align="center" rowspan="1" colspan="1">−12</td><td valign="top" align="center" rowspan="1" colspan="1">−4.5011</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">L-CUN</td><td valign="top" align="center" rowspan="1" colspan="1">163</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">−93</td><td valign="top" align="center" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">−3.9564</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">L-SOG</td><td valign="top" align="center" rowspan="1" colspan="1">90</td><td valign="top" align="center" rowspan="1" colspan="1">−24</td><td valign="top" align="center" rowspan="1" colspan="1">−72</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">−3.8977</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">L-PostCG/LING/CAL</td><td valign="top" align="left" rowspan="1" colspan="1">R-LING</td><td valign="top" align="center" rowspan="1" colspan="1">852</td><td valign="top" align="center" rowspan="1" colspan="1">−6</td><td valign="top" align="center" rowspan="1" colspan="1">−60</td><td valign="top" align="center" rowspan="1" colspan="1">−6</td><td valign="top" align="center" rowspan="1" colspan="1">−4.7800</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">R-MTG</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">42</td><td valign="top" align="center" rowspan="1" colspan="1">−63</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">−3.3359</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">R-MTG</td><td valign="top" align="left" rowspan="1" colspan="1">L-CER-8</td><td valign="top" align="center" rowspan="1" colspan="1">129</td><td valign="top" align="center" rowspan="1" colspan="1">−36</td><td valign="top" align="center" rowspan="1" colspan="1">−57</td><td valign="top" align="center" rowspan="1" colspan="1">−51</td><td valign="top" align="center" rowspan="1" colspan="1">−3.4584</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">L-LING</td><td valign="top" align="center" rowspan="1" colspan="1">3542</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">−90</td><td valign="top" align="center" rowspan="1" colspan="1">27</td><td valign="top" align="center" rowspan="1" colspan="1">−4.4815</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">L-SMA</td><td valign="top" align="center" rowspan="1" colspan="1">775</td><td valign="top" align="center" rowspan="1" colspan="1">−3</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">60</td><td valign="top" align="center" rowspan="1" colspan="1">−4.3930</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">L-MTG</td><td valign="top" align="left" rowspan="1" colspan="1">L-MOG</td><td valign="top" align="center" rowspan="1" colspan="1">294</td><td valign="top" align="center" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">−81</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">−3.8720</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">R-MOG/ANG</td><td valign="top" align="left" rowspan="1" colspan="1">L-MTP</td><td valign="top" align="center" rowspan="1" colspan="1">732</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">−30</td><td valign="top" align="center" rowspan="1" colspan="1">−33</td><td valign="top" align="center" rowspan="1" colspan="1">−4.7765</td></tr></tbody></table><table-wrap-foot><p><italic>TAO, thyroid-associated ophthalmopathy; HC, healthy control; MNI, Montreal Neurological Institute; FC, functional connectivity; PostCG, postcentral gyrus; LING, lingual gyrus; CAL, calcarine; MTG, middle temporal gyrus; MOG, middle occipital gyrus; ANG, angular gyrus; CUN, cuneus; SOG, superior occipital gyrus; CER, cerebellum; SMA, supplementary motor area; MTP, middle temporal pole</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Significant differences in seed-based FC between TAO patients and HCs.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Seed region</th><th valign="top" align="left">Regions</th><th valign="top" align="center">Clustersize</th><th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;">MNI coordination</th><th valign="top" align="center">P value</th></tr><tr><th/><th/><th/><th valign="top" align="center">X</th><th valign="top" align="center">Y</th><th valign="top" align="center">Z</th><th/></tr></thead><tbody><tr><td valign="top" align="left">R-PostCG/LING/CAL</td><td valign="top" align="left">L-LING</td><td valign="top" align="center">282</td><td valign="top" align="center">−12</td><td valign="top" align="center">−60</td><td valign="top" align="center">−12</td><td valign="top" align="center">−4.5011</td></tr><tr><td/><td valign="top" align="left">L-CUN</td><td valign="top" align="center">163</td><td valign="top" align="center">3</td><td valign="top" align="center">−93</td><td valign="top" align="center">24</td><td valign="top" align="center">−3.9564</td></tr><tr><td/><td valign="top" align="left">L-SOG</td><td valign="top" align="center">90</td><td valign="top" align="center">−24</td><td valign="top" align="center">−72</td><td valign="top" align="center">18</td><td valign="top" align="center">−3.8977</td></tr><tr><td valign="top" align="left">L-PostCG/LING/CAL</td><td valign="top" align="left">R-LING</td><td valign="top" align="center">852</td><td valign="top" align="center">−6</td><td valign="top" align="center">−60</td><td valign="top" align="center">−6</td><td valign="top" align="center">−4.7800</td></tr><tr><td/><td valign="top" align="left">R-MTG</td><td valign="top" align="center">29</td><td valign="top" align="center">42</td><td valign="top" align="center">−63</td><td valign="top" align="center">3</td><td valign="top" align="center">−3.3359</td></tr><tr><td valign="top" align="left">R-MTG</td><td valign="top" align="left">L-CER-8</td><td valign="top" align="center">129</td><td valign="top" align="center">−36</td><td valign="top" align="center">−57</td><td valign="top" align="center">−51</td><td valign="top" align="center">−3.4584</td></tr><tr><td/><td valign="top" align="left">L-LING</td><td valign="top" align="center">3542</td><td valign="top" align="center">3</td><td valign="top" align="center">−90</td><td valign="top" align="center">27</td><td valign="top" align="center">−4.4815</td></tr><tr><td/><td valign="top" align="left">L-SMA</td><td valign="top" align="center">775</td><td valign="top" align="center">−3</td><td valign="top" align="center">0</td><td valign="top" align="center">60</td><td valign="top" align="center">−4.3930</td></tr><tr><td valign="top" align="left">L-MTG</td><td valign="top" align="left">L-MOG</td><td valign="top" align="center">294</td><td valign="top" align="center">24</td><td valign="top" align="center">−81</td><td valign="top" align="center">15</td><td valign="top" align="center">−3.8720</td></tr><tr><td valign="top" align="left">R-MOG/ANG</td><td valign="top" align="left">L-MTP</td><td valign="top" align="center">732</td><td valign="top" align="center">0</td><td valign="top" align="center">−30</td><td valign="top" align="center">−33</td><td valign="top" align="center">−4.7765</td></tr></tbody></table></div>TAO, thyroid-associated ophthalmopathy; HC, healthy control; MNI, Montreal Neurological Institute; FC, functional connectivity; PostCG, postcentral gyrus; LING, lingual gyrus; CAL, calcarine; MTG, middle temporal gyrus; MOG, middle occipital gyrus; ANG, angular gyrus; CUN, cuneus; SOG, superior occipital gyrus; CER, cerebellum; SMA, supplementary motor area; MTP, middle temporal pole.</transformed-table></extracted-table></extracted-tables-set>